The Peptide Report
A head-to-head comparison of SLU-PP-332 and Cardarine (GW-501516) — two exercise mimetics with fundamentally different mechanisms. Here's how ERR-alpha activation stacks up against PPAR-delta agonism for fat oxidation and endurance.
A head-to-head breakdown of SLU-PP-332 and Cardarine (GW-501516) — the two most-discussed exercise mimetics. We compare mechanism, metabolic effects, and safety to help you choose the smarter option in 2026.
SLU-PP-332 and Cardarine (GW-501516) are both called exercise mimetics, but they work through entirely different pathways. Here's how they compare on mechanism, evidence, and safety in 2026.
A head-to-head comparison of SLU-PP-332 and Cardarine (GW-501516) — the two most-discussed exercise mimetics. We break down mechanism, endurance data, fat oxidation, and the safety story behind ERRα activation versus PPARδ agonism.
SLU-PP-332 and Cardarine are both labeled 'exercise in a pill,' but they hit completely different molecular targets. Here's how the ERRα/β/γ pan-agonist stacks up against the PPARδ agonist on mechanism, endurance science, and safety.
A head-to-head breakdown of SLU-PP-332 (ERRα/β/γ pan-agonist) versus Cardarine (GW-501516, a PPARδ agonist) across mechanism, mitochondrial biogenesis, safety, and legal status. Discover which modern exercise mimetic actually delivers metabolic results in 2026.
